tiprankstipranks
Hikma Pharmaceuticals PLC (GB:HIK)
LSE:HIK

Hikma Pharmaceuticals (HIK) Ownership - Who Owns Hikma Pharmaceuticals?

24 Followers

Hikma Pharmaceuticals (HIK) Ownership Overview

8.98%7.71%8.36%74.96%
8.36% Other Institutional Investors
74.96% Public Companies and
Individual Investors
The ownership structure of Hikma Pharmaceuticals (GB:HIK) stock is a mix of institutional, retail and individual investors. Approximately 16.07% of the company’s stock is owned by Institutional Investors, 8.98% is owned by Insiders and 74.96% is owned by Public Companies and Individual Investors.
The ownership structure of Hikma Pharmaceuticals (GB:HIK) stock is a mix of institutional, retail and individual investors. Approximately 16.07% of the company’s stock is owned by Institutional Investors, 8.98% is owned by Insiders and 74.96% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 13, 2024
Brian Hoffmann
Divisional President
Sold£175914
Mar 13, 2024
Susan Ringdal
Vice President
Sold£156328
Mar 07, 2024
Julie Hill
Divisional Vice President
Sold£42212
Aug 10, 2023
Brian Hoffmann
Divisional President
Sold£130360

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
14,196,450Insider6.40%271,578,089
6,939,510Institution3.13%180,017,829
5,730,134Institution2.58%148,645,406
5,437,941Institution2.45%141,065,627
2,211,047Institution1.00%57,356,770
2,006,299Insider0.90%38,380,500
1,353,721Insider0.61%25,896,683
1,310,137Institution0.59%33,986,264
1,132,384Institution0.51%29,375,173
977,721Institution0.44%25,363,060

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
5,437,941Institution2.45%141,065,627
2,211,047Institution1.00%57,356,770
1,310,137Institution0.59%33,986,264
792,472Institution0.36%20,557,516
745,148Institution0.34%19,329,884
733,382Institution0.33%19,024,662
724,338Institution0.33%18,790,052
522,478Institution0.24%13,553,602
509,118Institution0.23%13,207,030
497,613Institution0.22%12,908,579

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,236,996Institution1.01%54,115,176
1,332,748Institution0.60%32,240,475
961,393Institution0.43%21,596,316
891,553Institution0.40%20,027,460
515,994Institution0.23%11,591,066
376,607Institution0.17%8,451,027
376,607Institution0.17%8,451,027
331,242Institution0.15%8,013,067
348,827Institution0.16%7,835,899
323,836Institution0.15%7,833,909

FAQ

Who Owns Hikma Pharmaceuticals PLC (GB:HIK)?
According to the latest TipRanks data, approximately 8.36% of the company's stock is held by institutional investors, 8.98% is held by insiders, and 74.96% is held by retail investors.
    What percentage of Hikma Pharmaceuticals PLC (GB:HIK) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 8.36% of Hikma Pharmaceuticals PLC (GB:HIK) stock is held by institutional investors.
      What percentage of Hikma Pharmaceuticals PLC (GB:HIK) stock is held by retail investors?
      According to the latest TipRanks data, approximately 74.96% of Hikma Pharmaceuticals PLC (GB:HIK) stock is held by retail investors.
        Who owns the most shares of Hikma Pharmaceuticals PLC (GB:HIK)?
        Said Darwazah owns the most shares of Hikma Pharmaceuticals PLC (GB:HIK).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis